Qomolangma Acquisition Corp.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023028267 Filed on April 07, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$170.0K	$200.0K	$200.0K
YoY Change	70.0%		33.33%
Cash & Equivalents	$167.8K	$196.5K
Short-Term Investments
Other Short-Term Assets	$230.0K	$240.0K	$240.0K
YoY Change
Inventory
Prepaid Expenses	$233.3K	$235.5K
Receivables
Other Receivables
Total Short-Term Assets	$401.1K	$432.0K	$430.0K
YoY Change	301.07%	179.49%	186.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$54.49M	$53.96M	$53.96M
YoY Change
Other Assets		$0.00	$0.00
YoY Change			-100.0%
Total Long-Term Assets	$54.49M	$53.96M	$53.96M
YoY Change	36223.76%	40470.44%	38442.86%
TOTAL ASSETS
Total Short-Term Assets	$401.1K	$432.0K	$430.0K
Total Long-Term Assets	$54.49M	$53.96M	$53.96M
Total Assets	$54.89M	$54.39M	$54.39M
YoY Change	21854.68%	18814.22%	18655.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$560.0K	$124.6K	$170.0K
YoY Change	1300.01%	91.69%	142.86%
Deferred Revenue
YoY Change
Short-Term Debt	$360.0K	$160.0K	$160.0K
YoY Change	80.0%		-20.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.084M	$371.2K	$370.0K
YoY Change	351.73%	39.27%	37.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.110M	$2.110M	$2.110M
YoY Change
Total Long-Term Liabilities	$2.110M	$2.110M	$2.110M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.084M	$371.2K	$370.0K
Total Long-Term Liabilities	$2.110M	$2.110M	$2.110M
Total Liabilities	$3.237M	$2.517M	$2.520M
YoY Change	1248.64%	844.29%	833.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$93.26K	$130.9K
YoY Change		-3426.96%
Common Stock	$166.00	$166.00
YoY Change		15.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.019M	$5.045M	$51.87M
YoY Change
Total Liabilities & Shareholders Equity	$54.89M	$54.39M	$54.39M
YoY Change	21854.68%	18814.22%	18655.17%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41518
CY2022	dei	Entity Registrant Name EntityRegistrantName	QOMOLANGMA Acquisition Corp.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3733656
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1178 Broadway
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	3rd Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10001
CY2022	dei	City Area Code CityAreaCode	(512)
CY2022	dei	Local Phone Number LocalPhoneNumber	340-7800
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	QOMO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6935623	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Friedman LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash Cash	196510	usd
CY2021Q4	us-gaap	Cash Cash	154565	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	235476	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	431986	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	154565	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	133000	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	53958681	usd
CY2022Q4	us-gaap	Assets Assets	54390667	usd
CY2021Q4	us-gaap	Assets Assets	287565	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	124599	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	65000	usd
CY2022Q4	qomo	Franchise Tax Payable FranchiseTaxPayable	45428	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	46115	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1500	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	155025	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	200000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	371167	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	266500	usd
CY2022Q4	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	36164	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2109200	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2516531	usd
CY2021Q4	us-gaap	Liabilities Liabilities	266500	usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	16000000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	16000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5273000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5273000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5273000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	5273000	shares
CY2022Q4	qomo	Common Stock Value1 CommonStockValue1	46828833	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	16000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	16000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1662623	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1662623	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1437500	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1437500	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	166	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	144	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4914221	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24856	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	130916	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3935	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5045303	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21065	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54390667	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	287565	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	174673	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3935	usd
CY2022	us-gaap	Franchisor Costs FranchisorCosts	45928	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-220601	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3935	usd
CY2022	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	437731	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	217130	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3935	usd
CY2022	qomo	Deferred Tax Provision DeferredTaxProvision	82279	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	134851	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3935	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21065	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	52730000	usd
CY2022	qomo	Sale Of Private Placement Units SaleOfPrivatePlacementUnits	2693725	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	673500	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-3031975	usd
CY2022	qomo	Offering Costs OfferingCosts	-1347030	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-43419193	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	3409640	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	134851	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5045303	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	25000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3935	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21065	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	134851	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3935	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	437731	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	36164	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	235476	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	59599	usd
CY2022	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	45428	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	46115	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-351050	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3935	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	53520950	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53520950	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	52730000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2693725	usd
	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1500	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	153525	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
CY2022	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	922775	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	540530	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	68000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	53913945	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	158500	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	41945	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	154565	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154565	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196510	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154565	usd
CY2022	qomo	Initial Classification Of Common Stock Subject To Redemption InitialClassificationOfCommonStockSubjectToRedemption	43419193	usd
CY2022	qomo	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2109200	usd
CY2022	qomo	Accretion Of Common Stock To Redemptions Value AccretionOfCommonStockToRedemptionsValue	3409640	usd
	qomo	Public Offering Costs Included In Accrued Expenses PublicOfferingCostsIncludedInAccruedExpenses	65000	usd
CY2022	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	875000	usd
CY2022	qomo	Deferred Underwriting Fees DeferredUnderwritingFees	2000000	usd
CY2022	qomo	Offering Cost OfferingCost	1347030	usd
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.15
CY2022	qomo	Maturity Days MaturityDays	P185D
CY2022	qomo	Trust Account Description TrustAccountDescription	Pursuant to Nasdaq listing rules, the Company’s initial Business Combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test.
CY2022	qomo	Aggregate Fair Market Percentage AggregateFairMarketPercentage	0.80	pure
CY2022	qomo	Financing Receivable Non Accrual To Outstanding Percent FinancingReceivableNonAccrualToOutstandingPercent	0.50	pure
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.15
CY2022	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	5000001	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	1	pure
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	10.15
CY2022Q4	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	10.15
CY2022Q4	us-gaap	Cash Cash	196510	usd
CY2022	qomo	Working Capital WorkingCapital	152362	usd
CY2022Q3	qomo	Effective Income Tax Rate Reconciliation At Federal Excise Tax Percentage EffectiveIncomeTaxRateReconciliationAtFederalExciseTaxPercentage	0.01	pure
CY2022Q3	qomo	Excise Tax Percentage ExciseTaxPercentage	0.01	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	196510	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	154565	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4222030	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	134851	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3935	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-3409640	usd
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-3274790	usd
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-3935	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1318250	shares
CY2022	qomo	Founder Shares Percentage FounderSharesPercentage	0.50	pure
CY2022	qomo	Temporary Equity Accretion To Redemption Value Adjustment1 TemporaryEquityAccretionToRedemptionValueAdjustment1	3409640	usd
CY2022	qomo	Gross Proceeds1 GrossProceeds1	-52730000	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3532910	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	1845550	usd
CY2022	qomo	Allocation Of Offering Costs Related To Redeemable Shares AllocationOfOfferingCostsRelatedToRedeemableShares	3932347	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	3409640	usd
CY2022	qomo	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	46828833	usd
CY2021Q3	qomo	Aggregate Amount AggregateAmount	200000	usd
CY2022Q4	qomo	Repaid Outstanding Balance RepaidOutstandingBalance	200000	usd
CY2022Q4	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	155025	usd
CY2021	qomo	Outstanding Promissory Note OutstandingPromissoryNote	200000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	1500000	usd
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	10
CY2022	us-gaap	Payments For Rent PaymentsForRent	10000	usd
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	28387	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	28387	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	53958681	usd
CY2022Q4	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5000000	shares
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	50000000	usd
CY2022Q4	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	750000	shares
CY2022Q4	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	273000	shares
CY2022Q4	qomo	Generating Gross Proceeds GeneratingGrossProceeds	2730000	usd
CY2022	qomo	Initial Public Offering Description InitialPublicOfferingDescription	Each Public Unit consists of one share of common stock (“Public Share”), one right (“Public Right”) and one redeemable warrant (“Public Warrant”). Each Public Right will convert into one-tenth (1/10) of one share of common stock upon the consummation of a Business Combination.
CY2022	qomo	Initial Public Offering Expiration InitialPublicOfferingExpiration	P5Y
CY2022	qomo	Public Shares Sold PublicSharesSold	5273000	shares
CY2022	qomo	Aggregate Purchase Price AggregatePurchasePrice	2605000	usd
CY2022	us-gaap	Partners Capital Account Units Sold In Private Placement PartnersCapitalAccountUnitsSoldInPrivatePlacement	8873	shares
CY2022	qomo	Private Placement Description PrivatePlacementDescription	Each Private Unit consists of one share of common stock (“Private Share”), one right (“Private Right”) and one redeemable warrant (“Private Warrant”). Each Private Right will convert into one-tenth (1/10) of one share of common stock upon the consummation of a Business Combination.
CY2021Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1437500	shares
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	25000	usd
CY2022Q4	qomo	Subject To Forfeiture Shares SubjectToForfeitureShares	187500	shares
CY2022	qomo	Issued And Outstanding Shares Percentage IssuedAndOutstandingSharesPercentage	0.20	pure
CY2022Q4	qomo	Shares Forfeited SharesForfeited	119250	shares
CY2022	qomo	Additional Units To Underwriters AdditionalUnitsToUnderwriters	750000	shares
CY2022Q4	qomo	Purchase Units PurchaseUnits	273000	shares
CY2022	qomo	Deferred Underwriting Discount Percentage DeferredUnderwritingDiscountPercentage	0.0175	pure
CY2022	qomo	Deferred Fee Percentage DeferredFeePercentage	0.04	pure
CY2022	qomo	Gross Proceeds GrossProceeds	2109200	usd
CY2022Q4	us-gaap	Shares Issued SharesIssued	16000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of the common stock are entitled to one vote for each share.
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1437500	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1437500	shares
CY2022Q4	qomo	Subject To Forfeiture Shares SubjectToForfeitureShares	187500	shares
CY2022	qomo	Initial Stockholders Percentage InitialStockholdersPercentage	0.20	pure
CY2022Q4	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	119250	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1662623	shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1662623	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	5273000	shares
CY2022	qomo	Redeem The Outstanding Warrants RedeemTheOutstandingWarrants	●in whole and not in part; ●at a price of $0.01 per warrant; ●upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the 30-day redemption period; ●if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the to the warrant holders.
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	36681	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	826	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	36164	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	517	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	826	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36681	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	826	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	36164	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	46115	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	309	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-826	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	35855	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	826	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82279	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.379	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	35855	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	826	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust		usd
CY2021Q4	qomo	Franchise Tax Payable FranchiseTaxPayable		usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent		usd
CY2021Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	qomo	Common Stock Value1 CommonStockValue1		usd
	us-gaap	Franchisor Costs FranchisorCosts		usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment		usd
	qomo	Deferred Tax Provision DeferredTaxProvision		usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty		usd
	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement		usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	qomo	Initial Classification Of Common Stock Subject To Redemption InitialClassificationOfCommonStockSubjectToRedemption		usd
	qomo	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
	qomo	Accretion Of Common Stock To Redemptions Value AccretionOfCommonStockToRedemptionsValue		usd
CY2022	qomo	Public Offering Costs Included In Accrued Expenses PublicOfferingCostsIncludedInAccruedExpenses		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Interest Paid InterestPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2022	qomo	Outstanding Promissory Note OutstandingPromissoryNote		usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred		usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	1.69	pure
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001894210

Files In Submission

Name	View Source	Status
0001213900-23-028267-index-headers.html	Edgar Link	pending
0001213900-23-028267-index.html	Edgar Link	pending
0001213900-23-028267.txt	Edgar Link	pending
0001213900-23-028267-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_qomolangma.htm	Edgar Link	pending
f10k2022ex31-2_qomolangma.htm	Edgar Link	pending
f10k2022ex32-1_qomolangma.htm	Edgar Link	pending
f10k2022ex32-2_qomolangma.htm	Edgar Link	pending
f10k2022ex4-7_qomolangma.htm	Edgar Link	pending
f10k2022_qomolangma.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qomo-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
qomo-20221231_cal.xml	Edgar Link	unprocessable
qomo-20221231_def.xml	Edgar Link	unprocessable
qomo-20221231_lab.xml	Edgar Link	unprocessable
qomo-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_qomolangma_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Qomolangma Acquisition Corp.

2023 Q1 Form 10-K Financial Statement

#000121390023028267 Filed on April 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission